Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/414011

Fatigue and cognitive performance change in MS: multifactorial with disparate influences

Hu, M.·Muhlert, N.·Robertson, N.·Winter, M.
View original source ↗Export metadata ↓

Abstract

BackgroundFatigue is a common and disabling symptom in Multiple Sclerosis (MS) with a variety of direct and indirect influences, but remains poorly understood. Performance-based and self-report measures of fatigue are only weakly correlated and may have independent predictors. We adopted a multifactorial approach, utilising a measure of concurrent cognitive performance change in order to examine the clinical, psychological, and cognitive factors influencing subjective and objective fatigue in MS.\n\nMethodsSixty-one people with MS were assessed. Subjective fatigue was measured using the Modified Fatigue Impact Scale, Fatigue Assessment Instrument, and a Visual Analogue Scale (VAS). The Conners Continuous Performance Test 3 (CCPT3) and VAS were administered before and after two hours of cognitive testing, representing a period of cognitive effort. The differences in scores formed measures of objective performance fatigue and subjective fatigue change, respectively. We examined differences across baseline fatigue, fatigue change and performance change classifications, using regression analysis to uncover predictors of subjective fatigue and performance change.\n\n\n\nO_TBL View this table:\norg.highwire.dtl.DTLVardef@81ec81org.highwire.dtl.DTLVardef@1ce44e8org.highwire.dtl.DTLVardef@10e1bdeorg.highwire.dtl.DTLVardef@147c5ceorg.highwire.dtl.DTLVardef@10b831f_HPS_FORMAT_FIGEXP M_TBL O_FLOATNOTable 1.C_FLOATNO O_TABLECAPTIONDemographic and clinical features of the sample\n\nC_TABLECAPTION C_TBL ResultsDepression, sleep, and emotion-focused coping each predicted baseline fatigue and together explained 53.5% of variance. Increased subjective fatigue was linked with anxiety, lower self-efficacy and gender. Cognitive performance change on the CCPT3 was however predicted by estimated general cognitive ability, self-efficacy and post-intervention fatigue.\n\nConclusionSubjective fatigue in MS is a multifactorial construct, with subjective and objective cognitive performance fatigue largely influenced by indirect psychological and cognitive factors. The varying factors driving subjective and objective fatigue suggest that future studies need to take into account these disparate aspects when developing fatigue assessment tools. Targeting influential fatigue drivers such as psychological variables, and even using gender specific interventions may have the potential to improve the burden of fatigue and quality of life of people with MS.

Explore related subjects

neurosciencePreprint

Keep this discovery

BibTeXRIS

Hu, M., Muhlert, N., Robertson, N., Winter, M.. 2018-09-13. Fatigue and cognitive performance change in MS: multifactorial with disparate influences. https://doi.org/10.1101/414011

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗